文献速递耳科与耳神经

慢性化脓性中耳炎的长期医疗利用与结局

Long-Term Health Utilization and Outcomes in Chronic Suppurative Otitis Media.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-10-12

该回顾性队列纳入175例慢性化脓性中耳炎患者,平均随访3.5年。患者平均就诊9.5次、处方4.7次、手术1.7次,人均费用3927至20776美元。药物治疗者69%复发,中位复发时间4个月;鼓室成形术和鼓室乳突切除术的中位复发时间分别为5年和7年(P=.73)。最近一次就诊时41%患者有中度或更差感音神经性听力损失。

要点

  • 慢性化脓性中耳炎医疗利用和费用高,复发常见
  • 药物治疗后69%复发,中位复发时间4个月
  • 手术短期至中期控制疾病优于药物治疗

核心结论

  • 慢性化脓性中耳炎是重大公共卫生问题,医疗利用和费用高。
  • 手术在实现短期至中期非活动性疾病方面优于药物治疗。
  • 患者感音神经性听力损失负担高。

研究设计与样本

  • 回顾性队列研究,纳入175例慢性化脓性中耳炎患者。
  • 患者来自学术耳科门诊,首次就诊时间2011年3月至2016年11月。
  • 平均年龄49.5±1.5岁,53%为女性,平均随访3.5±0.3年。

主要发现

  • 患者平均耳科就诊9.5±0.5次,处方4.7±0.4次,手术1.7±0.1次。
  • 估计人均费用范围为3927至20776美元。
  • 药物治疗下69%患者疾病复发,中位复发时间4个月。
  • 鼓室成形术和鼓室乳突切除术的中位复发时间分别为5年和7年(P=.73)。
  • 最近一次就诊时,41%患者有中度或更差感音神经性听力损失。

关键数值与推荐

  • 慢性化脓性中耳炎定义为国际疾病分类编码诊断,且至少1次活动性发作(穿孔伴耳漏),并有慢性耳感染病史。

临床怎么用

  • 临床应关注慢性化脓性中耳炎的高复发率和听力损失风险。
  • 手术可作为短期至中期控制疾病的有效选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report health utilization patterns and outcomes of medical and surgical management in patients with chronic suppurative otitis media (CSOM). STUDY DESIGN: Retrospective cohort. SETTING: Academic otology clinic. METHODS: This study included 175 patients with CSOM with a first clinic visit at our institution between March 2011 and November 2016. All patients displayed a diagnosis of CSOM by International Classification of Diseases code, had at least 1 episode of active CSOM (defined as perforation with otorrhea), and had a documented history of chronic ear infections. The mean age was 49.5 ± 1.5 years, 53% were female, and mean follow-up time was 3.5 ± 0.3 years. RESULTS: Patients had an average of 9.5 ± 0.5 otology visits, 4.7 ± 0.4 prescriptions, and 1.7 ± 0.1 surgeries, with estimated per patient cost ranging from $3927 to $20,776. Under medical management, 69% of patients displayed recurrence of disease, with a median time to recurrence of 4 months. For tympanoplasty and tympanomastoidectomy, median time to recurrence was similar at 5 and 7 years, respectively (P = .73). At the most recent visit, the prevalence of all patients with CSOM displaying moderate or worse sensorineural hearing loss (SNHL) was 41%. CONCLUSIONS: CSOM represents a major public health issue with high health care utilization and associated costs. Surgery is superior to medical therapy for achieving short- to medium-term inactive disease. Patients with CSOM display a high SNHL burden.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Thai A, Aaron KA, Kaufman AC, et al. Long-Term Health Utilization and Outcomes in Chronic Suppurative Otitis Media. Otolaryngol Head Neck Surg. 2021. PMID: 34637356. doi:10.1177/01945998211050626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。